DBV Technologies S.A.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: DBV Technologies S.A.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: France
Headquarters city: Chatillon
Headquarters country: France
Fiscal year end: December
Ticker symbol: DBVT
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001613780
LEI: 969500PVBQFWQKVDMD80
ISIN: FR0010417345
Wikidata ID: Q5204430

Board of directors

Follow this board

Adora Ndu · Director
Since 2024
Daniel B. Soland · Director
Since 2023
Daniel Tasse · Director · CHIEF EXECUTIVE OFFICER
Since 2023
Felix Baker · Director Overboarded
Since 2025
Julian Baker · Director Overboarded
Since 2025
Philina Lee · Director
Since 2025
Timothy E. Morris · Director
Since 2023

Chief executives

Daniel Tasse · Chief Executive Officer

Dates unknown

Board connections

6 of this board's directors also sit on 17 other boards. 17 are in the same sector.

Shared director Other board Same sector +1 more in the list below

ACADIA Pharmaceuticals Inc. Same sector
via Adora Ndu, Daniel B. Soland, Felix Baker and Julian Baker
BeOne Medicines Ltd. Same sector
via Felix Baker and Julian Baker
Bicycle Therapeutics plc Same sector
via Felix Baker and Julian Baker
Denali Therapeutics Inc. Same sector
via Felix Baker and Julian Baker
Immunocore Holdings plc Same sector
via Felix Baker and Julian Baker
Incyte Corp. Same sector
via Felix Baker and Julian Baker
Kiniksa Pharmaceuticals International plc Same sector
via Felix Baker and Julian Baker
Kodiak Sciences Inc Same sector
via Felix Baker and Julian Baker
Kymera Therapeutics Inc. Same sector
via Felix Baker and Julian Baker
Madrigal Pharmaceuticals Inc. Same sector
via Felix Baker and Julian Baker
Neurogene Inc. Same sector
via Felix Baker and Julian Baker
Prelude Therapeutics Incorporated Same sector
via Felix Baker and Julian Baker
Replimune Group Inc. Same sector
via Felix Baker and Julian Baker
TScan Therapeutics Inc. Same sector
via Felix Baker and Julian Baker
vTv Therapeutics Inc. Same sector
via Felix Baker and Julian Baker
Aquestive Therapeutics Inc. Same sector
via Timothy E. Morris
REGENXBIO Inc. Same sector
via Daniel Tasse

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $15,511,198; 7 sales by 2 insiders

Date	Insider	Transaction	Shares	Price	Value
Jul 29, 2026	Mohideen Pharis Officer (Chief Medical Officer)	Open-market sale	−464	$2.70	$1,253
Jan 29, 2026	Mohideen Pharis Officer (Chief Medical Officer)	Open-market sale	−534	$4.86	$2,595
Dec 18, 2025	EPIC Bpifrance Member of 10% owner group	Open-market sale	−1,292,103	$4.19	$5,413,912
Dec 17, 2025	EPIC Bpifrance Member of 10% owner group	Open-market sale	−2,036,990	$4.84	$9,859,032
Dec 17, 2025	EPIC Bpifrance Member of 10% owner group	Open-market sale	−40,000	$5.28	$211,200
Nov 21, 2025	Boucinha Virginie Officer (Chief Financial Officer)	Grant or award	+32,000	—	—
Nov 21, 2025	Trapp Kevin Michael Officer (Chief Commercial Officer)	Grant or award	+55,000	—	—
Nov 21, 2025	Mohideen Pharis Officer (Chief Medical Officer)	Open-market sale	−1,624	$2.77	$4,498
Nov 21, 2025	Mohideen Pharis Officer (Chief Medical Officer)	Grant or award	+44,000	—	—
Nov 20, 2025	Mohideen Pharis Officer (Chief Medical Officer)	Open-market sale	−6,496	$2.88	$18,708
Jul 29, 2025	Mohideen Pharis Officer (Chief Medical Officer)	Open-market sale	−464	$2.22	$1,030
May 22, 2025	Mohideen Pharis Officer (Chief Medical Officer)	Open-market sale	−397	$1.84	$730
Jan 30, 2025	Mohideen Pharis Officer (Chief Medical Officer)	Open-market sale	−600	$0.85	$510
Nov 25, 2024	Mohideen Pharis Officer (Chief Medical Officer)	Open-market sale	−565	$0.57	$322
Nov 22, 2024	Mohideen Pharis Officer (Chief Medical Officer)	Open-market sale	−342	$0.53	$181

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

Abivax SA Nasdaq: ABVX · Paris, France Organization Cellectis S.A. Nasdaq: CLLS · Paris, Lle-De-France, France Organization 3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization

Questions about DBV Technologies S.A.

Who is the CEO of DBV Technologies S.A.?

Daniel Tasse is DBV Technologies S.A.'s Chief Executive Officer.

How many directors are on DBV Technologies S.A.'s board?

DBV Technologies S.A.'s board has 7 directors: Adora Ndu, Daniel B. Soland, Daniel Tasse, Felix Baker, Julian Baker, Philina Lee and Timothy E. Morris.

Are DBV Technologies S.A. insiders buying or selling shares?

Over the last 12 months, DBV Technologies S.A. insiders made no open-market purchases and sold $15.5 million of shares in 7 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is DBV Technologies S.A. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="dbv-technologies-sa"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.